Resonant Medical hosts exclusive dinner event at ASTRO 2008

Boston, MA – September 22, 2008  Resonant Medical brought together some of the brightest minds in Radiation Oncology as they hosted an exclusive dinner event at ASTRO 2008 in Boston. Chairmen from some of the most prestigious and influential centers in the US, Canada and Europe were on hand to join in presentations and a panel discussion on "The Future of Radiation Oncology: A Scientific and Business Perspective"

Presenters and Panelists include:
Dr. Robert Kuske, Radiation Oncologist, Arizona Oncology Services - Current Trends in Breast Radiation Oncology: An Update
Dr. David Parda, Chair, Radiation Oncology, Allegheny General Hospital - A Chairman's View: The State of the State of Radiation Oncology
Dr. John Suh, Chair, Radiation Oncology, Cleveland Clinic - The Future of the Prostate: In or Out
Dr. Alan Pollack, Chair, Radiation Oncology, University of Miami - Perspective of a new Chair: Back to the Future

About Resonant Medical
Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products. Originally developed at McGill University Health Center, Resonant's technologies are available in more than 50 cancer centers in the U.S., Canada and Europe, helping cancer centers make significant improvements in radiation therapy planning, verification and delivery--advancing patient care.

For more information, please contact:

Michèle Jémus
Chief Financial Officer
Resonant Medical
M.: 514.518-0449
T.: 514-985-2442 x 270
F.: 514.985-9662
mjemus@resonantmedical.com